NewGenIvf Group Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of April 2025 for NewGenIvf Group Limited, a foreign private issuer headquartered in Bangkok, Thailand. The report details a corporate action regarding the company's capital structure rather than operational financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is exclusively focused on a reverse stock split announcement.
Material Changes
The primary material change is a one-for-ten reverse stock split announced on April 16, 2025, with an effective date of May 5, 2025. Key details include:
- Share Reduction: Outstanding Class A Ordinary Shares will decrease from 7,302,819 to approximately 730,282.
- Trading Details: Shares will trade on the Nasdaq Capital Market under the symbol "NIVF" with a new CUSIP number (G0544E121).
- Fractional Shares: No fractional shares will be issued; shareholders entitled to fractions will receive one full share.
- Derivatives Adjustment: All outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable share count by ten.
Guidance, Outlook, and Risks
The filing contains no management commentary on future financial guidance, operational outlook, or specific risk factors beyond the mechanics of the stock split. No unusual items or contingencies were disclosed in this text.
Investor Verification Checklist
- Confirm the new CUSIP number (G0544E121) for trading purposes.
- Verify the adjustment of any personal holdings of options or warrants held in brokerage accounts.
- Check the effective trading date of May 5, 2025, for split-adjusted pricing.
- Review the company's Form 20-F for the most recent audited financial statements, as this 6-K does not contain financial data.